SciFi Futures
← Capabilities
Neurotechnology/Foundational science

Measurable neural biomarkers of mood and affect

Identifying signals in brain activity that track a person's mood, motivation and emotional state accurately enough to serve as a control variable.

State of the art

Closed-loop neuromodulation driven by an intracranial amygdala biomarker produced rapid sustained improvement in one patient with treatment-resistant depression (Nature Medicine 2021); FDA approved adaptive DBS with sensing for Parkinson's in 2025.

What’s blocking it
  • Biomarkers do not generalize across people; each requires weeks of intracranial mapping
  • Ground truth is subjective self-report, so the mapping cannot be validated objectively
  • Emotion is not a small set of dials; no evidence that discrete states like "ersatz dread" are separately addressable

Who’s working on it

  • Katherine ScangosResearcher
    UCSF Dolby Family Center for Mood Disorders

    Led the 2021 n-of-1 study that found a personalized amygdala gamma biomarker and used it to trigger closed-loop stimulation for depression

  • Helen MaybergResearcher
    Icahn School of Medicine at Mount Sinai

    Her group used a sensing DBS device to identify a recording-based biomarker tracking recovery from treatment-resistant depression (NIH-reported, 2023)

  • Sameer ShethResearcher
    Baylor College of Medicine

    Runs intracranial-recording-guided DBS trials for depression at Baylor and co-founded Motif Neurotech (PI of its 2026 RESONATE study)

  • Multi-subject program mapping personalized iEEG mood biomarkers before chronic closed-loop DBS, with a sham-controlled phase

  • Completed an FDA early feasibility study of a skull-embedded depression stimulator in 2025, reporting remission in its third patient

  • ARPA-H EVIDENTProgram

    Behavioral-health program funding teams to collect objective data on which patients respond to rapid-acting mental-health interventions; Motif Neurotech selected in 2026

What to invest in

KindInvestmentScale
researchMulti-site intracranial mood-mapping cohorts large enough to test cross-subject biomarker generalization$$ $10M – $100M

Sci-fi concepts in reach

Penfield mood organgatingdirectSurgically partitioned multiple mindsindirectSimstim (recorded full-sensory experience)direct

Sources